Skip Navigation LinksHome > June 2010 - Volume 58 - Issue 5 > Low Level of Serum Interleukin 27 in Patients With Systemic...
Journal of Investigative Medicine:
doi: 10.231/JIM.0b013e3181d88f7b
Brief Report

Low Level of Serum Interleukin 27 in Patients With Systemic Lupus Erythematosus

Li, Ting-Ting MM*; Zhang, Tao MM*; Chen, Gui-Mei MM*; Zhu, Qing-Qing MM*; Tao, Jin-Hui MM*†; Pan, Hai-Feng MD*; Ye, Dong-Qing MD*

Collapse Box


T helper 17 (TH17) cells are beginning to be implicated in the pathogenesis of systemic lupus erythematosus (SLE). Recent studies have shown that interleukin 27 (IL-27) controls the development of TH17. However, whether IL-27 plays a role in the development of SLE is still unclear. In the present work, we investigated the serum IL-27 level in SLE and its relations to disease activity. Fifty-six patients with SLE and 30 healthy volunteers were recruited. Serum IL-27 levels were detected by enzyme-linked immunosorbent assay. The clinical and laboratory parameters were collected from medical records or by questionnaire. The serum IL-27 level in SLE patients was significantly lower than that in healthy controls (P < 0.001). Compared with SLE patients without nephritis, patients with nephritis had a significantly decreased serum IL-27 level (P < 0.05). However, there was no significant difference between less active and more active SLE (P > 0.05). Correlation analysis between serum IL-27 levels and SLE disease activity index showed no association (P > 0.05). In summary, a decrease in serum IL-27 level in patients with SLE suggested that this cytokine might be implicated in the pathomechanism of this disease.

© 2010 American Federation for Medical Research


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.